The prevalence of chronic sinusitis in China is about 8 percent, meaning it affects approximately 107 million people, ...

Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for ...

Treatment with tezepelumab has been effective for sinonasal symptoms in patients with severe, uncontrolled asthma and a ...

An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial ...

A global drug trial to test the effectiveness of the asthma drug tezepelumab in treating nasal polyps has shown significant ...

Endoscopic sinus surgery is effective but sometimes requires subsequent revision. Monoclonal antibody therapies are a treatment option for patients with severe chronic rhinosinusitis with nasal polyps ...

Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP ... may be necessary when other treatments haven't worked. Surgery helps open your sinuses, allowing for better drainage and airflow.

Nasal steroid sprays. Biologics. Surgery. These are some of the treatments your doctor may have recommended to manage your nasal polyps. The first-line treatment is medication management ...

FDA reviews GSK depemokimab for asthma and CRSwNP, with a decision expected by December 2025. Phase 3 data shows improvements ...

Amgen and AstraZeneca have announced full results from the Phase III, registrational WAYPOINT trial showing that Tezspire ...

nasal sprays, and home remedies such as drinking fluids and using steam. In severe cases, a doctor might suggest surgery to clear blocked sinuses or remove polyps. Allergies can cause sinus ...